Indeed, studies performed in patients and in mice with advanced melanoma showed that blockade of both PD-1 and Tim-3 acts synergistically to enhance TA-specific CD8+ T cell numbers and functions, resulting in decreased tumor growth (82–84). Here, HAVCR2 is linked to neoplasm.